Cited 0 times in Scipus Cited Count

Pertuzumab, trastuzumab, and docetaxel for HER2-positive early or locally advanced breast cancer in the neoadjuvant setting: Efficacy and safety analysis of a randomized phase III study in Asian patients (PEONY)

DC Field Value Language
dc.contributor.authorShao, Z-
dc.contributor.authorPang, D-
dc.contributor.authorYang, H-
dc.contributor.authorLi, W-
dc.contributor.authorWang, S-
dc.contributor.authorCui, S-
dc.contributor.authorLiao, N-
dc.contributor.authorWang, Y-
dc.contributor.authorWang, C-
dc.contributor.authorChang, YC-
dc.contributor.authorWang, H-
dc.contributor.authorKang, SY-
dc.contributor.authorJiang, Z-
dc.contributor.authorLi, J-
dc.contributor.authorZhou, J-
dc.contributor.authorAlthaus, B-
dc.contributor.authorMao, Y-
dc.contributor.authorEng-Wong, J-
dc.date.accessioned2020-11-17T05:33:05Z-
dc.date.available2020-11-17T05:33:05Z-
dc.date.issued2019-
dc.identifier.issn0008-5472-
dc.identifier.urihttp://repository.ajou.ac.kr/handle/201003/19155-
dc.language.isoen-
dc.titlePertuzumab, trastuzumab, and docetaxel for HER2-positive early or locally advanced breast cancer in the neoadjuvant setting: Efficacy and safety analysis of a randomized phase III study in Asian patients (PEONY)-
dc.typeArticle-
dc.contributor.affiliatedAuthor강, 석윤-
dc.type.localJournal Papers-
dc.identifier.doi10.1158/1538-7445.SABCS18-P6-17-17-
dc.citation.titleCancer research-
dc.citation.volume79-
dc.citation.number4S-
dc.citation.date2019-
dc.citation.startPageP6-17-17-
dc.citation.endPageP6-17-17-
dc.identifier.bibliographicCitationCancer research, 79(4S). : P6-17-17-P6-17-17, 2019-
dc.embargo.liftdate9999-12-31-
dc.embargo.terms9999-12-31-
dc.identifier.eissn1538-7445-
dc.relation.journalidJ000085472-
Appears in Collections:
Journal Papers > School of Medicine / Graduate School of Medicine > Hematology-Oncology
Files in This Item:
There are no files associated with this item.

qrcode

해당 아이템을 이메일로 공유하기 원하시면 인증을 거치시기 바랍니다.

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

Browse